Blood pressure and mortality in U.S. Veterans with chronic kidney disease: A cohort study

Annals of Internal Medicine

Volumn 159, Issue 4, 2013, Pages 233-242

  Kovesdy, Csaba P ^a   Bleyer, Anthony J ^b   Molnar, Miklos Z ^c   Ma, Jennie Z ^d   Sim, John J ^e   Cushman, William C ^a   Quarles, L Darryl ^f   Kalantar Zadeh, Kamyar ^g  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b WAKE FOREST SCHOOL OF MEDICINE   (United States)

^c SEMMELWEIS UNIVERSITY   (Hungary)

^d UNIVERSITY OF VIRGINIA   (United States)

^e College of Medicine ^*  (United States)

^f UNIVERSITY OF TENNESSEE COLLEGE OF MEDICINE   (United States)

^g UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CHOLESTEROL; CREATININE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HEMOGLOBIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOOP DIURETIC AGENT; POTASSIUM; THIAZIDE DIURETIC AGENT;

AGED; ALBUMIN BLOOD LEVEL; ARTICLE; BODY MASS; CEREBROVASCULAR DISEASE; CHARLSON COMORBIDITY INDEX; CHOLESTEROL BLOOD LEVEL; CHRONIC KIDNEY DISEASE; CLINICAL ASSESSMENT; COHORT ANALYSIS; CORONARY ARTERY DISEASE; CORRELATIONAL STUDY; CREATININE BLOOD LEVEL; DIABETES MELLITUS; DIASTOLIC BLOOD PRESSURE; FEMALE; GENDER; GLOMERULUS FILTRATION RATE; HEMOGLOBIN BLOOD LEVEL; HUMAN; MAJOR CLINICAL STUDY; MALE; MICROALBUMINURIA; MORTALITY; POTASSIUM BLOOD LEVEL; PRIORITY JOURNAL; PROTEINURIA; SYSTOLIC BLOOD PRESSURE; VETERAN;

EID: 84882244594     PISSN: 00034819     EISSN: 15393704     Source Type: Journal    
DOI: 10.7326/0003-4819-159-4-201308200-00004     Document Type: Article

References (47)

1. Lewington S, Clarke R, Qizilbash N, Peto R, Collins R; Prospective Studies Collaboration. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet. 2002;360:1903-13. [PMID: 12493255]
2. Whelton PK, He J, Appel LJ, Cutler JA, Havas S, Kotchen TA, et al; National High Blood Pressure Education Program Coordinating Committee. Primary prevention of hypertension: clinical and public health advisory from The National High Blood Pressure Education Program. JAMA. 2002;288:1882-8. [PMID: 12377087]
3. Gasowski J, Fagard RH, Staessen JA, Grodzicki T, Pocock S, Boutitie F, et al; INDANA Project Collaborators. Pulsatile blood pressure component as predictor of mortality in hypertension: a meta-analysis of clinical trial control groups. J Hypertens. 2002;20:145-51. [PMID: 11791038]
4. van den Hoogen PC, Feskens EJ, Nagelkerke NJ, Menotti A, Nissinen A, Kromhout D. The relation between blood pressure and mortality due to coronary heart disease among men in different parts of the world. Seven Countries Study Research Group. N Engl J Med. 2000;342:1-8. [PMID: 10620642]
5. Vasan RS, Larson MG, Leip EP, Evans JC, O'Donnell CJ, Kannel WB, et al. Impact of high-normal blood pressure on the risk of cardiovascular disease. N Engl J Med. 2001;345:1291-7. [PMID: 11794147]
6. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, et al; Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. National Heart, Lung, and Blood Institute. Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension. 2003;42:1206-52. [PMID: 14656957]
7. Klassen PS, Lowrie EG, Reddan DN, DeLong ER, Coladonato JA, Szczech LA, et al. Association between pulse pressure and mortality in patients undergoing maintenance hemodialysis. JAMA. 2002;287:1548-55. [PMID: 11911757]
8. Kannel WB, Wilson PW, Nam BH, D'Agostino RB, Li J. A likely explanation for the J-curve of blood pressure cardiovascular risk. Am J Cardiol. 2004;94: 380-4. [PMID: 15276113]
9. Domanski M, Mitchell G, Pfeffer M, Neaton JD, Norman J, Svendsen K, et al; MRFIT Research Group. Pulse pressure and cardiovascular disease-related mortality: follow-up study of the Multiple Risk Factor Intervention Trial (MRFIT). JAMA. 2002;287:2677-83. [PMID: 12020303]
10. Kidney Disease Outcomes Quality Initiative (K/DOQI). K/DOQI clinical practice guidelines on hypertension and antihypertensive agents in chronic kidney disease. Am J Kidney Dis. 2004;43:S1-290. [PMID: 15114537]
11. KDIGO Clinical Practice Guideline for the Management of Blood Pressure in Chronic Kidney Disease. Kidney Int Suppl. 2012;2:337-414.
12. Somes GW, Pahor M, Shorr RI, Cushman WC, Applegate WB. The role of diastolic blood pressure when treating isolated systolic hypertension. Arch Intern Med. 1999;159:2004-9. [PMID: 10510985]
13. Kovesdy CP, Lott EH, Lu JL, Malakauskas SM, Ma JZ, Molnar MZ, et al. Hyponatremia, hypernatremia, and mortality in patients with chronic kidney disease with and without congestive heart failure. Circulation. 2012;125:677-84. [PMID: 22223429]
14. Kovesdy CP, Lott EH, Lu JL, Malakauskas SM, Ma JZ, Molnar MZ, et al. Outcomes associated with microalbuminuria: effect modification by chronic kidney disease. J Am Coll Cardiol. 2013;61:1626-33. [PMID: 23500283]
15. U.S. Department of Veterans Affairs. VIReC Research User Guide: VHA Decision Support System-Clinical National Data Extracts, 2nd ed. Hines, IL: Veterans Affairs Information Resource Center; 2009. Accessed at www.virec.research.va.gov/RUGs/RUG-DSS-NDE-2nd-Ed-CY09-ER.pdf on 19 June 2013.
16. Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF 3rd, Feldman HI, et al; CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration). A new equation to estimate glomerular filtration rate. Ann Intern Med. 2009;150: 604-12. [PMID: 19414839]
17. National Kidney Foundation. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis. 2002;39:S1-266. [PMID: 11904577]
18. U.S. Department of Veterans Affairs. Data Quality Update: Race. Hines, IL: Veterans Affairs Information Resource Center; 2009. Accessed at www.virec.research.va.gov/Reports/DQU/DQU-RACE-Nov-CY09-ER.pdf on 19 June 2013.
19. U.S. Department of Veterans Affairs. VIReC Research User Guide: VHA Pharmacy Prescription Data, 2nd ed. Hines, IL: Veterans Affairs Information Resource Center; 2008. Accessed at www.virec.research.va.gov/RUGs/RUG-PBM-2nd-Ed-CY08-ER.pdf on 19 June 2013.
20. U.S. Department of Veterans Affairs. VIReC Research User Guide: FY2006 VHA Medical SAS Inpatient Datasets. Hines, IL: Veterans Affairs Information Resource Center; 2007. Accessed at www.virec.research.va.gov/rugs/MedSAS-Archive/IP/RUG-MedSAS-IP-FY06-ER.pdf on 19 June 2013.
21. U.S. Department of Veterans Affairs. VIReC Research User Guide: FY2006 VHA Medical SAS Outpatient Datasets. Hines, IL: Veterans Affairs Information Resource Center; 2007. Accessed at www.virec.research.va.gov/RUGs/MedSAS-Archive/OP/RUG-MedSAS-OP-FY06-ER.pdf on 19 June 2013.
22. Deyo RA, Cherkin DC, Ciol MA. Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol. 1992;45:613-9. [PMID: 1607900]
23. Arnold N, Sohn MW, Maynard C, Hynes DM. VIReC Technical Report 2: VA-NDI Mortality Data Merge Project. Hines, IL: Veterans Affairs Information Resource Center; 2006. Accessed at www.virec.research.va.gov/Reports/TR/TR-VA-NDI-Mortality-CY06-ER.pdf on 19 June 2013.
24. Agarwal R. Blood pressure components and the risk for end-stage renal disease and death in chronic kidney disease. Clin J Am Soc Nephrol. 2009;4: 830-7. [PMID: 19339424]
25. Kovesdy CP, Trivedi BK, Kalantar-Zadeh K, Anderson JE. Association of low blood pressure with increased mortality in patients with moderate to severe chronic kidney disease. Nephrol Dial Transplant. 2006;21:1257-62. [PMID: 16421161]
26. Royston P, Sauerbrei W. Multivariable modeling using cubic regression splines: a principled approach. Stata J. 2007;7:45-70.
27. Thadhani R, Tonelli M. Cohort studies: marching forward. Clin J Am Soc Nephrol. 2006;1:1117-23. [PMID: 17699334]
28. Duranti E, Imperiali P, Sasdelli M. Is hypertension a mortality risk factor in dialysis? Kidney Int Suppl. 1996;55:S173-4. [PMID: 8743547]
29. Fleischmann EH, Bower JD, Salahudeen AK. Risk factor paradox in hemodialysis: better nutrition as a partial explanation. ASAIO J. 2001;47:74-81. [PMID: 11199320]
30. Iseki K, Miyasato F, Tokuyama K, Nishime K, Uehara H, Shiohira Y, et al. Low diastolic blood pressure, hypoalbuminemia, and risk of death in a cohort of chronic hemodialysis patients. Kidney Int. 1997;51:1212-7. [PMID: 9083288]
31. Port FK, Hulbert-Shearon TE, Wolfe RA, Bloembergen WE, Golper TA, Agodoa LY, et al. Predialysis blood pressure and mortality risk in a national sample of maintenance hemodialysis patients. Am J Kidney Dis. 1999;33:507-17. [PMID: 10070915]
32. Zager PG, Nikolic J, Brown RH, Campbell MA, Hunt WC, Peterson D, et al. "U" curve association of blood pressure and mortality in hemodialysis patients. Medical Directors of Dialysis Clinic, Inc. Kidney Int. 1998;54:561-9. [PMID: 9690224]
33. Berl T, Hunsicker LG, Lewis JB, Pfeffer MA, Porush JG, Rouleau JL, et al; Collaborative Study Group. Impact of achieved blood pressure on cardiovascular outcomes in the Irbesartan Diabetic Nephropathy Trial. J Am Soc Nephrol. 2005;16:2170-9. [PMID: 15930097]
34. Greenberg JA. Removing confounders from the relationship between mortality risk and systolic blood pressure at low and moderately increased systolic blood pressure. J Hypertens. 2003;21:49-56. [PMID: 12544435]
35. Bangalore S, Messerli FH, Wun CC, Zuckerman AL, DeMicco D, Kostis JB, et al; Treating to New Targets Steering Committee and Investigators. J-curve revisited: An analysis of blood pressure and cardiovascular events in the Treating to New Targets (TNT) Trial. Eur Heart J. 2010;31:2897-908. [PMID: 20846991]
36. Messerli FH, Mancia G, Conti CR, Hewkin AC, Kupfer S, Champion A, et al. Dogma disputed: can aggressively lowering blood pressure in hypertensive patients with coronary artery disease be dangerous? Ann Intern Med. 2006;144: 884-93. [PMID: 16785477]
37. Peralta CA, Norris KC, Li S, Chang TI, Tamura MK, Jolly SE, et al; KEEP Investigators. Blood pressure components and end-stage renal disease in persons with chronic kidney disease: the Kidney Early Evaluation Program (KEEP). Arch Intern Med. 2012;172:41-7. [PMID: 22232147]
38. Farnett L, Mulrow CD, Linn WD, Lucey CR, Tuley MR. The J-curve phenomenon and the treatment of hypertension. Is there a point beyond which pressure reduction is dangerous? JAMA. 1991;265:489-95. [PMID: 1824642]
39. Plantinga LC, Miller ER 3rd, Stevens LA, Saran R, Messer K, Flowers N, et al; Centers for Disease Control and Prevention Chronic Kidney Disease Surveillance Team. Blood pressure control among persons without and with chronic kidney disease: US trends and risk factors 1999-2006. Hypertension. 2009;54:47-56. [PMID: 19470881]
40. Peralta CA, Shlipak MG, Wassel-Fyr C, Bosworth H, Hoffman B, Martins S, et al. Association of antihypertensive therapy and diastolic hypotension in chronic kidney disease. Hypertension. 2007;50:474-80. [PMID: 17664397]
41. Barzilay JI, Howard AG, Evans GW, Fleg JL, Cohen RM, Booth GL, et al. Intensive blood pressure treatment does not improve cardiovascular outcomes in centrally obese hypertensive individuals with diabetes: the Action to Control Cardiovascular Risk in Diabetes (ACCORD) Blood Pressure Trial. Diabetes Care. 2012;35:1401-5. [PMID: 22723577]
42. Cushman WC, Evans GW, Byington RP, Goff DC Jr, Grimm RH Jr, Cutler JA, et al; ACCORD Study Group. Effects of intensive blood-pressure control in type 2 diabetes mellitus. N Engl J Med. 2010;362:1575-85. [PMID: 20228401]
43. Klahr S, Levey AS, Beck GJ, Caggiula AW, Hunsicker L, Kusek JW, et al. The effects of dietary protein restriction and blood-pressure control on the progression of chronic renal disease. Modification of Diet in Renal Disease Study Group. N Engl J Med. 1994;330:877-84. [PMID: 8114857]
44. Wright JT Jr, Bakris G, Greene T, Agodoa LY, Appel LJ, Charleston J, et al; African American Study of Kidney Disease and Hypertension Study Group. Effect of blood pressure lowering and antihypertensive drug class on progression of hypertensive kidney disease: results from the AASK trial. JAMA. 2002;288:2421-31. [PMID: 12435255]
45. Ruggenenti P, Perna A, Loriga G, Ganeva M, Ene-Iordache B, Turturro M, et al; REIN-2 Study Group. Blood-pressure control for renoprotection in patients with non-diabetic chronic renal disease (REIN-2): multicentre, randomised controlled trial. Lancet. 2005;365:939-46. [PMID: 15766995]
46. Busby WJ, Campbell AJ, Robertson MC. Is low blood pressure in elderly people just a consequence of heart disease and frailty? Age Ageing. 1994;23:69-74. [PMID: 8010177]
47. Kim JW, Bosworth HB, Voils CI, Olsen M, Dudley T, Gribbin M, et al. How well do clinic-based blood pressure measurements agree with the mercury standard? J Gen Intern Med. 2005;20:647-9. [PMID: 16050862]